Annual EBITDA:
$1.29B-$199.71M(-13.38%)Summary
- As of today, RPRX annual EBITDA is $1.29 billion, with the most recent change of -$199.71 million (-13.38%) on December 31, 2024.
- During the last 3 years, RPRX annual EBITDA has fallen by -$161.27 million (-11.09%).
- RPRX annual EBITDA is now -51.18% below its all-time high of $2.65 billion, reached on December 31, 2019.
Performance
RPRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$428.43M+$218.63M(+104.21%)Summary
- As of today, RPRX quarterly EBITDA is $428.43 million, with the most recent change of +$218.63 million (+104.21%) on September 30, 2025.
- Over the past year, RPRX quarterly EBITDA has dropped by -$306.64 million (-41.72%).
- RPRX quarterly EBITDA is now -67.97% below its all-time high of $1.34 billion, reached on December 31, 2019.
Performance
RPRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$1.53B-$306.64M(-16.66%)Summary
- As of today, RPRX TTM EBITDA is $1.53 billion, with the most recent change of -$306.64 million (-16.66%) on September 30, 2025.
- Over the past year, RPRX TTM EBITDA has dropped by -$10.52 million (-0.68%).
- RPRX TTM EBITDA is now -42.31% below its all-time high of $2.66 billion, reached on June 30, 2020.
Performance
RPRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RPRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -13.4% | -41.7% | -0.7% |
| 3Y3 Years | -11.1% | +122.9% | +60.7% |
| 5Y5 Years | -51.2% | -17.0% | -41.8% |
RPRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -13.4% | +39.2% | -41.7% | +680.7% | -19.3% | +65.2% |
| 5Y | 5-Year | -51.2% | +39.2% | -42.9% | +680.7% | -41.8% | +65.2% |
| All-Time | All-Time | -51.2% | +63.4% | -68.0% | +680.7% | -42.3% | +250.5% |
RPRX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $428.43M(+104.2%) | $1.53B(-16.7%) |
| Jun 2025 | - | $209.80M(-60.7%) | $1.84B(-3.1%) |
| Mar 2025 | - | $534.18M(+48.0%) | $1.90B(+47.1%) |
| Dec 2024 | $1.29B(-13.4%) | $361.00M(-50.9%) | $1.29B(-16.3%) |
| Sep 2024 | - | $735.07M(+172.6%) | $1.54B(+60.8%) |
| Jun 2024 | - | $269.63M(+465.5%) | $960.30M(+2.2%) |
| Mar 2024 | - | -$73.77M(-112.0%) | $939.51M(-37.0%) |
| Dec 2023 | $1.49B(+60.7%) | $613.00M(+304.8%) | $1.49B(+47.4%) |
| Sep 2023 | - | $151.44M(-39.1%) | $1.01B(-3.9%) |
| Jun 2023 | - | $248.84M(-48.0%) | $1.05B(-10.9%) |
| Mar 2023 | - | $478.97M(+260.1%) | $1.18B(+27.3%) |
| Dec 2022 | $928.56M(-36.1%) | $133.00M(-30.8%) | $928.39M(-2.7%) |
| Sep 2022 | - | $192.21M(-49.1%) | $954.39M(-10.9%) |
| Jun 2022 | - | $377.79M(+67.6%) | $1.07B(-25.8%) |
| Mar 2022 | - | $225.39M(+41.8%) | $1.44B(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $1.45B(-10.2%) | $159.00M(-48.5%) | $1.45B(-10.0%) |
| Sep 2021 | - | $308.85M(-58.9%) | $1.61B(-11.4%) |
| Jun 2021 | - | $750.68M(+219.5%) | $1.82B(+22.6%) |
| Mar 2021 | - | $234.97M(-26.6%) | $1.49B(-8.2%) |
| Dec 2020 | $1.62B(-38.9%) | $320.00M(-38.0%) | $1.62B(-38.6%) |
| Sep 2020 | - | $516.36M(+24.4%) | $2.64B(-0.8%) |
| Jun 2020 | - | $415.08M(+13.1%) | $2.66B(+3.2%) |
| Mar 2020 | - | $367.16M(-72.6%) | $2.58B(-2.7%) |
| Dec 2019 | $2.65B(+89.4%) | $1.34B(+148.5%) | $2.65B(+102.2%) |
| Sep 2019 | - | $538.29M(+61.4%) | $1.31B(+69.8%) |
| Jun 2019 | - | $333.59M(-23.8%) | $771.09M(+76.2%) |
| Mar 2019 | - | $437.50M | $437.50M |
| Dec 2018 | $1.40B(+43.7%) | - | - |
| Dec 2017 | $972.96M(+23.0%) | - | - |
| Dec 2016 | $791.08M(-8.3%) | - | - |
| Dec 2015 | $862.44M | - | - |
FAQ
- What is Royalty Pharma plc annual EBITDA?
- What is the all-time high annual EBITDA for Royalty Pharma plc?
- What is Royalty Pharma plc annual EBITDA year-on-year change?
- What is Royalty Pharma plc quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Royalty Pharma plc?
- What is Royalty Pharma plc quarterly EBITDA year-on-year change?
- What is Royalty Pharma plc TTM EBITDA?
- What is the all-time high TTM EBITDA for Royalty Pharma plc?
- What is Royalty Pharma plc TTM EBITDA year-on-year change?
What is Royalty Pharma plc annual EBITDA?
The current annual EBITDA of RPRX is $1.29B
What is the all-time high annual EBITDA for Royalty Pharma plc?
Royalty Pharma plc all-time high annual EBITDA is $2.65B
What is Royalty Pharma plc annual EBITDA year-on-year change?
Over the past year, RPRX annual EBITDA has changed by -$199.71M (-13.38%)
What is Royalty Pharma plc quarterly EBITDA?
The current quarterly EBITDA of RPRX is $428.43M
What is the all-time high quarterly EBITDA for Royalty Pharma plc?
Royalty Pharma plc all-time high quarterly EBITDA is $1.34B
What is Royalty Pharma plc quarterly EBITDA year-on-year change?
Over the past year, RPRX quarterly EBITDA has changed by -$306.64M (-41.72%)
What is Royalty Pharma plc TTM EBITDA?
The current TTM EBITDA of RPRX is $1.53B
What is the all-time high TTM EBITDA for Royalty Pharma plc?
Royalty Pharma plc all-time high TTM EBITDA is $2.66B
What is Royalty Pharma plc TTM EBITDA year-on-year change?
Over the past year, RPRX TTM EBITDA has changed by -$10.52M (-0.68%)